Ringafema

Medicinal product

(Invented) name

Ringafema

Active substance (s)

Etonogestrelis/Etinilestradiolis

Strength

120 µg/15 µg/24 val.

Pharmaceutical form

vartojimo į makštį sistema

Route (s) of administration

vartoti į makštį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G02BB01, Vaginal ring with progestogen and estrogen

Marketing authorisation holder

Viatris Limited, Airija

Date of authorisation

2017-09-28

Date of renewal

2022-07-27

Documents

4138 Ringafema II PL 2024 06 06.docx

4138 Pakuotės lapelis 2024 06 06.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/3721/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

3 sav. per 24 val. iš žiedo išsiskiria	1 vnt.
Etonogestrelis	120 µg
Etinilestradiolis	15 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
98016	84112	1084112	paketėlis	N1		Receptinis	LT/1/17/4138/001	Netiekiama	-	-	No	-	-	Download
98017	84113	1084113	paketėlis	N3		Receptinis	LT/1/17/4138/002	Netiekiama	-	-	No	-	-
98018	84114	1084114	paketėlis	N6		Receptinis	LT/1/17/4138/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-12-31	Išregistruotas
2022-07-27	Perregistruotas
2017-09-28	Registruotas